SPF 50+ SUNSCREEN PREPARATIONS (Anthelios)

Clinical Indication

Borderline Substance: only for patients with photosensitive disorder with widespread dysplastic lesions and/or a history of skin cancer

Comments

Restricted Green. Patients should be encouraged to purchase sun screens OTC as per LLR Self-Care Guidelines

Date of classification

June 2025

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.